CVS Health Recommendation
Considering 30-days investment horizon, and your above average risk tolerance our recommendation regarding CVS Health Corporation is 'Strong Buy'
For the selected time horizon CVS Health Corporation has a risk adjusted performance of 0.1381, jensen alpha of 0.2789, total risk alpha of 0.2996, sortino ratio of 0.4201 and treynor ratio of 0.517
Macroaxis provides buy, hold, or sell suggestion on CVS Health to complement and cross-verify current analyst consensus
on CVS Health Corporation. Our buy, hold, or sell recommendation engine determines the organization potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure CVS Health is not overpriced, please confirm all CVS Health fundamentals including its Revenue
, Cash Flow from Operations
, Retained Earnings
, as well as the relationship
between Cash per Share
and Price to Earnings To Growth
. Given that CVS Health
has Price to Earning
times, we suggest you validate CVS Health Corporation market performance and probability of bankruptcy to make sure the company can sustain itself next year given your prevailing risk tolerance and investing horizon.
CVS Health Greeks
CVS Health Volatility Alert
CVS Health Corporation exhibits relatively low volatility with skewness of 0.68 and kurtosis of -0.29. However, we advice investors to further investigate CVS Health Corporation to make sure all market statistics is disseminated and is consistent with investors' estimations about CVS Health upside potential.